-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Pliant Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Pliant Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 60.7M shares, a 1.75% increase year-over-year.
- Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 58.7M shares, a 39.8% increase from 2022.
- Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 42M shares, a 17.2% increase from 2021.
- Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 35.8M shares, a 67.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)